Oscar Cabrera-Marante
Overview
Explore the profile of Oscar Cabrera-Marante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcinuno S, Lalueza A, Gil-Etayo F, Diaz-Simon R, Lizasoain I, Moraga A, et al.
Front Immunol
. 2024 Aug;
15:1443096.
PMID: 39176097
Introduction: Influenza virus infection can cause a range of clinical symptoms, including respiratory failure (RF) and even death. The mechanisms responsible for the most severe forms of the disease are...
2.
Garcinuno S, Lalueza A, Gil-Etayo F, Diaz-Simon R, Lizasoain I, Moraga A, et al.
Front Immunol
. 2024 Aug;
15:1472919.
PMID: 39176083
[This corrects the article DOI: 10.3389/fimmu.2024.1443096.].
3.
Segura-Tudela A, Lopez-Nevado M, Nieto-Lopez C, Garcia-Jimenez S, Diaz-Madronero M, Delgado A, et al.
J Clin Immunol
. 2024 Feb;
44(3):61.
PMID: 38363452
Human inborn errors of immunity (IEI) comprise a group of diseases resulting from molecular variants that compromise innate and adaptive immunity. Clinical features of IEI patients are dominated by susceptibility...
4.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al.
Genome Med
. 2024 Jan;
16(1):6.
PMID: 38184654
No abstract available.
5.
Cabrera-Marante O, Garcinuno S, Pleguezuelo D, Gil-Etayo F, Tenica I, de Frias E, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139202
The presence of antiphospholipid antibodies (aPLs) is associated with antiphospholipid syndrome (APS), characterized by thrombosis and obstetric morbidity. aPLs included in APS classification criteria are lupus anticoagulant, anti-cardiolipin and anti-beta-2-glycoprotein-I...
6.
Arroyo-Sanchez D, Luczkowiak J, Delgado R, Cabrera-Marante O, Paz-Artal E
J Clin Immunol
. 2023 May;
43(6):1072-1074.
PMID: 37145391
No abstract available.
7.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al.
Genome Med
. 2023 Apr;
15(1):22.
PMID: 37020259
Background: We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN,...
8.
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, et al.
medRxiv
. 2022 Nov;
PMID: 36324795
Background: We previously reported inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity in 1-5% of unvaccinated patients with life-threatening COVID-19, and auto-antibodies against type I IFN in...
9.
Lopez-Nevado M, Ortiz-Martin J, Serrano C, Perez-Saez M, Lopez-Lorenzo J, Gil-Etayo F, et al.
J Clin Immunol
. 2022 Sep;
43(1):165-180.
PMID: 36066697
Somatic mutations in the ten-eleven translocation methylcytosine dioxygenase 2 gene (TET2) have been associated to hematologic malignancies. More recently, biallelic, and monoallelic germline mutations conferring susceptibility to lymphoid and myeloid...
10.
Garcinuno S, Gil-Etayo F, Mancebo E, Lopez-Nevado M, Lalueza A, Diaz-Simon R, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743021
NK degranulation plays an important role in the cytotoxic activity of innate immunity in the clearance of intracellular infections and is an important factor in the outcome of the disease....